Skip to content

Patient Registry of Posner-Schlossman Syndrome

Patient Registry of Posner-Schlossman Syndrome

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03233477
Enrollment
180
Registered
2017-07-28
Start date
2014-07-31
Completion date
2024-07-31
Last updated
2020-10-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Posner Schlossman Syndrome

Keywords

Posner Schlossman Syndrome, cytokine expression, cytomegalovirus

Brief summary

Posner-Schlossman syndrome, or glaucomatocyclitic crisis, is a condition characterized by recurrent, acute attacks of mild, nongranulomatous, anterior uveitis accompanied by markedly elevated intraocular pressure. Most of patients are the 20 to 50-year-old young adults, with unilateral eye involvement. PSS was originally deemed benign, but is now recognized as a relatively rare cause of chronic secondary glaucoma,especially in patients with recurrent episodes. This relatively rare disease is likely the result of the infections of a variety of organisms, and the bulk of literature supports the cytomegalovirus (CMV) as the leading cause. This study is an observational study that does not interfere with the normal clinical diagnosis and treatment process. The investigators in this study focus on observing the clinical symptoms and outcome of PSS, analyzing the factors that affect the prognosis of PSS, studying the association of its pathogenesis with the psychological status and the behavioral types of PSS patients; exploring the relationship between infection (CMV, HSV, Hp) and PSS; and studying the changes of local and systemic cytokine expression and its significance in patients with PSS.

Interventions

None listed

Sponsors

Peking University
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
12 Years to 80 Years
Healthy volunteers
Yes

Inclusion criteria

* Volunteer to take part in this study and sign informed consent by oneself or the patient's legal representative * Clinical diagnosis of Posner-Schlossman Syndrome, age-related cataract, or primary open-angle glaucoma * Live in Beijing, China or being able to visit the Peking University Third Hospital every year after the beginning of the study or whenever the disease relapses

Exclusion criteria

* Fit any

Design outcomes

Primary

MeasureTime frameDescription
demographic characteristicsup to 10 yearsage, sex, education level, systemic disease, mental state
visual acuityup to 10 yearsuncorrected visual acuity and best corrected visual acuity
intraocular pressureup to 10 yearsGoldmann
slit-lamp examinationup to 10 yearsanterior segment
fundus photographup to 10 yearsanalysis the morphology of optic nerve head
OCTup to 10 yearszess
visual fieldup to 10 yearsHumphrey visual field
blood serumup to 10 years8ml
aqueous humorup to 10 years0.2ml
tissuein the operationiris and& or trabecular meshwork tissue abandoned in the anti-glaucoma operation

Countries

China

Contacts

Primary ContactShushan Li, MD
shushan_li@yeah.net0086-135-5237-4266

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026